Clinical Trials Logo

Morality clinical trials

View clinical trials related to Morality.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06420479 Recruiting - Clinical trials for Cardiovascular Diseases

The Causal Effect of Bariatric Surgery on Cardiovascular Disease and Mortality

Start date: January 1, 2024
Phase:
Study type: Observational [Patient Registry]

The association between weight, and cardiovascular disease and mortality is well established, however, the causal effect of weight-loss in midlife on these outcomes is less clear. Bariatric surgery results in substantial weight-loss and is an ideal candidate to study the causal effects of weight-loss. We propose a project that will use causal inference and machine learning methods to answer two important questions: 1. Is bariatric surgery effective for reducing cardiovascular disease and mortality, and if so, for who? 2. Which type of bariatric surgery (gastric bypass or sleeve gastrectomy) is most effective, and for who? We will use data from various Swedish registers to identify individuals with obesity who are eligible for bariatric surgery. We will then compare cardiovascular and mortality outcomes among those undergoing different types of bariatric surgery with those receiving non-surgical obesity management using causal inference methods. We will use causal forests and expert knowledge to estimate indiviual treatment effects, and identify the groups of patients who benefit the most from these surgeries.

NCT ID: NCT06287905 Recruiting - Morality Clinical Trials

A Comparative Study of Using Scorpion Antivenom Versus Scorpion Antivenom and Prazosin

Start date: February 1, 2023
Phase: Phase 4
Study type: Interventional

Interventional study designed for the evaluation of characters and the outcome of scorpion sting patients will admit to Sohag University Hospitals in 2 randomized groups. The first group will receive scorpion antivenom only whether by the intravenous or the intramuscular route of administration. The second group will receive a combination of prazosin plus scorpion antivenom whether by the intravenous or the intramuscular route of administration. Both groups will receive proper first aid and supportive treatment

NCT ID: NCT06087315 Recruiting - Sepsis Clinical Trials

Evaluation of a Multi-country Medical Oxygen Program

REAL-MOXY
Start date: November 27, 2023
Phase:
Study type: Observational

REAL-MOXY is a set of 5 mixed methods studies designed to understand how oxygen and pulse oximetry are used (or not used) at a facility level, to identify opportunities and barriers for strengthening oxygen systems for beneficiaries, users and managers.

NCT ID: NCT05730894 Recruiting - Morality Clinical Trials

Predictors of Mortality in Patients With VA-Extracorporeal Membrane Oxygenation.

ECMO
Start date: February 28, 2023
Phase:
Study type: Observational

Venoarterial extracorporeal membrane oxygenation (VA-ECMO) support is a lifesaving tool used to treat cardiogenic shock, acute heart failure, or extracorporeal cardiopulmonary resuscitation(CPR). However, its use is associated with significant complications, including mortality. We aim to conduct a retrospective observational study of all patients at Heart Hospital who required VA-ECMO support due to cardiogenic shock during 1/06/2016 and 1/06/2022 to report the incidence of in-hospital mortality among patients who required VA-ECMO along with the predictors of mortality. Data will be collected to identify baseline characteristics and outcomes including clinical variables predictive of poor outcomes.

NCT ID: NCT05677789 Recruiting - COVID-19 Clinical Trials

Defining COVID-19 Infection Severity on Presentation to Hospital

Start date: January 4, 2023
Phase:
Study type: Observational [Patient Registry]

In the assessment of severity in coronavirus disease 2019 (COVID-19), the modified Brit_x0002_ish Thoracic Society (mBTS),CURB65 et al. rules identifies patients with severe pneumonia but not patients who might be suitable for home management. A multicentre prospective study was conducted to derive and validate a practical severity assessment model for stratifying adults hospitalised with COVID-19 into different management groups.

NCT ID: NCT05675761 Recruiting - COVID-19 Clinical Trials

The Efficacy and Safety of Azovudine in the Treatment of COVID-19

Start date: January 4, 2023
Phase:
Study type: Observational

This study is a prospective, multicenter clinical study. It is intended to discuss the efficacy of starting Azovudine treatment as early as possible for all types of patients of COVID-19, the time of remission of specific symptoms, the proportion of patients with severe diseases, oxygen and conditions, and related adverse reactions, so as to understand the efficacy and safety of Azovudine treatment in all types of COVID-19, and provide real world data support for the treatment of the majority of COVID-19 patients.

NCT ID: NCT05585593 Recruiting - Quality of Life Clinical Trials

Registry for Hypoparathyroidism Wuerzburg

Start date: October 18, 2017
Phase:
Study type: Observational

Long-term conventional treatment of chronic hypoparathyroidism does not fully restore calcium homeostasis leading to increased morbidity, emergency events and reduced subjective health status. To further investigate general morbidity, hypocalcemic events, subjective and daily life performance in patients with chronic hypoparathyroidism a standardized interview as well as blood sampling and examinations such as echocardiography and renal ultrasound are performed.

NCT ID: NCT05382065 Recruiting - Anemia Clinical Trials

Anemia and Duration of Mechanical Ventilation

Start date: July 8, 2022
Phase:
Study type: Observational

In mechanically ventilated patients in intensive care unit, anemia is commonly seen and it is probably associated with adverse outcomes including mortality. We aim to investigate the impact of duration of anemia and the duration of mechanical ventilation as well as clinical outcomes in critically ill patients in intensive care unit who required ventilatory support >96 hr.

NCT ID: NCT05307003 Recruiting - Delirium Clinical Trials

Trazodone vs. Quetiapine for the Treatment of ICU Delirium

TQDelirium
Start date: April 1, 2023
Phase:
Study type: Observational

This is a single-center, prospective observational pilot study. The objective of this study is to evaluate the effectiveness of trazodone as compared to quetiapine, in the management of ICU delirium in adult (>=18 years old) surgical and medical ICU patients. The investigators will compare outcomes such as delirium duration, delirium-free days, coma-free days, in-hospital mortality, 28-day mortality, hospital length of stay (LOS), ICU LOS, mechanical ventilator days, complications, adverse effects, rescue medication use, delirium symptom severity, sleep duration, and sleep quality among participants receiving trazodone or quetiapine. The investigators hypothesize participants receiving trazodone will be associated with a shorter duration of delirium, decreased delirium severity, and improved sleep quality compared to participants receiving quetiapine.

NCT ID: NCT05288023 Recruiting - Morality Clinical Trials

Azithromycin for Child Survival in Niger: Programmatic Trial (AVENIR)

AVENIR
Start date: December 1, 2022
Phase: Phase 4
Study type: Interventional

The MORDOR trial found that biannual distribution of azithromycin to children 1-59 months old reduced child mortality. The World Health Organization (WHO) released conditional guidelines for this intervention, which include targeting azithromycin distributions to children 1-11 months of age in high mortality settings. The proposed trial aims to demonstrate and evaluate large-scale implementation of azithromycin to children aged 1-11 months old in the context of a programmatic setting while monitoring mortality and resistance antimicrobial resistance.